Diagnostic Accuracy of Tongue Swabs for Tuberculosis Using a Common Protocol for Xpert MTB/RIF Ultra Testing: A Multi-Country Assessment
Margaretha de Vos(FIND), César Ugarte‐Gil(The University of Texas Medical Branch at Galveston), Monde Muyoyeta(Centre for Infectious Disease Research in Zambia), Payam Nahid(University of California, San Francisco), Kristin Kremer(National Institute for Public Health and the Environment), Claudia M. Denkinger(Heidelberg University), Wentzel Dowling(National Health Laboratory Service), John Bimba(Bingham University), Bukola Ajide(Bingham University), Yukari C. Manabe(Johns Hopkins University), Louis Henry Kamulegeya(Makerere University), Morten Rühwald(FIND), Dinh Van Luong(Hanoi Medical University), Sam Marconi(Christian Medical College, Vellore), Nchimunya Hapeela(University of Cape Town), Devasahayam Jesus Christopher(Christian Medical College, Vellore), Adithya Cattamanchi(University of California, San Francisco), David Alland(Rutgers, The State University of New Jersey), Grant Theron(South African Medical Research Council), Loren Rockman(Stellenbosch University), Danaida Marcelo(La Salle University), Jerrold J. Ellner(Rutgers, The State University of New Jersey), Lydia Nakiyingi(Makerere University), Adam Penn‐Nicholson(FIND), Brian Shuma(Centre for Infectious Disease Research in Zambia), Hung Van Nguyen(Hanoi Medical University), Hien Thi Thu Le(University of California, San Francisco), Maunank Shah(Johns Hopkins University), Charles Yu(La Salle University), Susan E. Dorman(Medical University of South Carolina), Karla G. Alí-Francia(Universidad Peruana Cayetano Heredia), April Borkman(Medical University of South Carolina), Caitlin A. Moe(University of California, Irvine Medical Center), Rudie Desravines(Frontier Science Foundation)
Cited by 7
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548
Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis
|European Respiratory Journal|2014|532